Research output per year
Research output per year
- 17 results
Search results
-
2023
CAR-T Cell Therapy: the Efficacy and Toxicity Balance
Chohan, K. L., Siegler, E. L. & Kenderian, S. S., Apr 2023, In: Current Hematologic Malignancy Reports. 18, 2, p. 9-18 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Who wins the combat, CAR or TCR?
Yun, K., Siegler, E. L. & Kenderian, S. S., Oct 2023, In: Leukemia. 37, 10, p. 1953-1962 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
2022
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Kankeu Fonkoua, L. A., Sirpilla, O., Sakemura, R., Siegler, E. L. & Kenderian, S. S., Jun 16 2022, In: Molecular Therapy Oncolytics. 25, p. 69-77 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned
Can, I., Cox, M. J., Siegler, E. L., Sakemura, R. & Kenderian, S. S., Apr 2022, In: Experimental Hematology. 108, p. 1-7 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
2021
In vivo CART cell imaging: Paving the way for success in CART cell therapy
Sakemura, R., Can, I., Siegler, E. L. & Kenderian, S. S., Mar 26 2021, In: Molecular Therapy Oncolytics. 20, p. 625-633 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review
Shakshouk, H., Tkaczyk, E. R., Cowen, E. W., el-Azhary, R. A., Hashmi, S. K., Kenderian, S. J. & Lehman, J. S., Sep 2021, In: Transplantation and Cellular Therapy. 27, 9, p. 738-746 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Omics analyses provide insights to CART cell therapy resistance
Cox, M. J. & Kenderian, S. S., 2021, In: Journal of Translational Genetics and Genomics. 5, 2, p. 80-88 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies
Sakemura, R., Cox, M. J., Hefazi, M., Siegler, E. L. & Kenderian, S. S., 2021, In: Leukemia and Lymphoma. 62, 9, p. 2052-2063 12 p.Research output: Contribution to journal › Review article › peer-review
-
2020
A Concise Review of Neurologic Complications Associated with Chimeric Antigen Receptor T-cell Immunotherapy
Ruff, M. W., Siegler, E. L. & Kenderian, S. S., Nov 2020, In: Neurologic clinics. 38, 4, p. 953-963 11 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview
Mohty, M., Dulery, R., Gauthier, J., Malard, F., Brissot, E., Aljurf, M., Bazarbachi, A., Chabanon, C., Kharfan-Dabaja, M. A., Savani, B. N., Huang, H., Kenderian, S. S., Perales, M. A., Yakoub-Agha, I. & Nagler, A., Aug 1 2020, In: Bone Marrow Transplantation. 55, 8, p. 1525-1532 8 p.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: Implication for future therapies
Sterner, R. M. & Kenderian, S. S., Jan 1 2020, In: Current opinion in hematology. 27, 1, p. 41-48 8 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
Siegler, E. L. & Kenderian, S. S., Aug 28 2020, In: Frontiers in immunology. 11, 1973.Research output: Contribution to journal › Review article › peer-review
Open Access11 Scopus citations -
2019
CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives
Mohty, M., Gautier, J., Malard, F., Aljurf, M., Bazarbachi, A., Chabannon, C., Kharfan-Dabaja, M. A., Savani, B. N., Huang, H., Kenderian, S., Nagler, A. & Perales, M. A., Dec 1 2019, In: Leukemia. 33, 12, p. 2767-2778 12 p.Research output: Contribution to journal › Review article › peer-review
25 Scopus citations -
2017
Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse
Kenderian, S. S., Porter, D. L. & Gill, S., Feb 1 2017, In: Biology of Blood and Marrow Transplantation. 23, 2, p. 235-246 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access46 Scopus citations -
The microbiome and immune regulation after transplantation
Tabibian, J. H. & Kenderian, S. S., Jan 2017, In: Transplantation. 101, 1, p. 56-62 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access10 Scopus citations -
2016
Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia
Dias, A., Kenderian, S. J., Westin, G. F. & Litzow, M. R., Aug 1 2016, In: Current Hematologic Malignancy Reports. 11, 4, p. 253-264 12 p.Research output: Contribution to journal › Review article › peer-review
12 Scopus citations -
2014
Chimeric antigen receptor T-cell therapy to target hematologic malignancies
Kenderian, S. S., Ruella, M., Gill, S. & Kalos, M., Nov 15 2014, In: Cancer research. 74, 22, p. 6383-6389 7 p.Research output: Contribution to journal › Review article › peer-review
33 Scopus citations